News & Updates
Filter by Specialty:
Intramuscular injection preferable to IV infusion of ibalizumab for PWH
Ibalizumab delivered via intramuscular (IM) injection is not only safe and well-tolerated but also succeeds in viral suppression among heavily treatment experienced (HTE) people living with HIV (PWH), making IM the preferred method of administration among participants of the TMB-302 study.
Intramuscular injection preferable to IV infusion of ibalizumab for PWH
22 Mar 2024Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
In highly viraemic pregnant women with chronic hepatitis B (CHB), stopping peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) immediately after delivery does not increase the risk of relapse or retreatment vs TDF cessation at ≥4 weeks postpartum. Early withdrawal of PP-TDF, combined with standard neonatal immunization schemes, is 100 percent effective in preventing mother-to-child transmission (MTCT).
Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
19 Mar 2024Bloodstream infection tied to ICU admission, death in children hospitalized for flu
Bloodstream infections rarely occur in children hospitalized for influenza but are associated with intensive care unit (ICU) admission, mechanical ventilation, longer hospital stay, and higher in-hospital mortality, according to a study.
Bloodstream infection tied to ICU admission, death in children hospitalized for flu
18 Mar 2024Broaden screening in patients with TB or HBV, says study
Patients with hepatitis B virus (HBV) infection are at heightened risk of latent tuberculosis (TB), while those with latent TB are also at increased risk of HBV infection, reveals a study. Notably, the risk of co-infection is highest among Asians and those born in high-incidence countries.